Structures by: Cherukuvada S.
Total: 82
C7H6O3,C4H5NO2
C7H6O3,C4H5NO2
IUCrJ (2015) 2, Pt 3 341-351
a=6.5133(3)Å b=8.1853(5)Å c=11.4965(6)Å
α=103.458(5)° β=93.925(4)° γ=113.018(5)°
C7H6O4,C4H5NO2
C7H6O4,C4H5NO2
IUCrJ (2015) 2, Pt 3 341-351
a=6.7358(8)Å b=6.9119(8)Å c=12.3937(9)Å
α=74.468(9)° β=85.298(8)° γ=73.28(1)°
2(C7H6O4),C4H5NO2
2(C7H6O4),C4H5NO2
IUCrJ (2015) 2, Pt 3 341-351
a=6.7323(2)Å b=12.1142(5)Å c=21.2077(8)Å
α=90° β=97.146(3)° γ=90°
C7H6O5,2(C4H5NO2)
C7H6O5,2(C4H5NO2)
IUCrJ (2015) 2, Pt 3 341-351
a=7.0213(3)Å b=8.8214(4)Å c=25.1416(12)Å
α=90° β=90° γ=90°
C7H6O5,2(C4H5NO2)
C7H6O5,2(C4H5NO2)
IUCrJ (2015) 2, Pt 3 341-351
a=4.9225(4)Å b=11.7839(10)Å c=13.8540(16)Å
α=97.248(8)° β=96.773(8)° γ=90.663(6)°
3(C7H6O4),C4H5NO2,3(H2O)
3(C7H6O4),C4H5NO2,3(H2O)
IUCrJ (2015) 2, Pt 3 341-351
a=9.3161(5)Å b=11.2092(3)Å c=13.7362(7)Å
α=102.926(3)° β=104.398(4)° γ=96.571(3)°
C7H6O3,C4H3NO2
C7H6O3,C4H3NO2
IUCrJ (2015) 2, Pt 3 341-351
a=10.8426(8)Å b=6.5202(4)Å c=16.1326(13)Å
α=90° β=106.391(8)° γ=90°
2(C7H6O3),C5H7NO2
2(C7H6O3),C5H7NO2
IUCrJ (2015) 2, Pt 3 341-351
a=40.692(3)Å b=5.4524(3)Å c=16.3546(9)Å
α=90° β=90° γ=90°
C7H6O4,C5H7NO2
C7H6O4,C5H7NO2
IUCrJ (2015) 2, Pt 3 341-351
a=6.6761(3)Å b=9.1128(4)Å c=10.9447(4)Å
α=93.397(3)° β=107.694(3)° γ=108.173(4)°
C7H6O4,C4H3NO2
C7H6O4,C4H3NO2
IUCrJ (2015) 2, Pt 3 341-351
a=12.5506(4)Å b=6.6807(2)Å c=26.1586(8)Å
α=90° β=98.815(3)° γ=90°
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
C4H6N4O3S2
Chem.Commun. (2016) 52, 5820
a=4.73060(10)Å b=21.6655(4)Å c=8.10690(10)Å
α=90° β=103.803(2)° γ=90°
C23H33ClFN3O
C23H33ClFN3O
CrystEngComm (2012) 14, 7 2367
a=17.0708(14)Å b=11.9644(10)Å c=11.0576(9)Å
α=90.00° β=106.1890(10)° γ=90.00°
C23H31ClFN3
C23H31ClFN3
CrystEngComm (2012) 14, 7 2367
a=7.485(10)Å b=8.578(9)Å c=16.794(18)Å
α=82.718(17)° β=85.478(17)° γ=84.883(11)°
C16H18N6O6
C16H18N6O6
CrystEngComm (2012) 14, 7 2579
a=7.883(2)Å b=8.697(3)Å c=12.506(4)Å
α=90.00° β=97.74(3)° γ=90.00°
C8H10N3O3
C8H10N3O3
CrystEngComm (2012) 14, 7 2579
a=6.971(6)Å b=19.508(17)Å c=7.260(6)Å
α=90.00° β=114.603(13)° γ=90.00°
C16H18N6O6
C16H18N6O6
CrystEngComm (2012) 14, 7 2579
a=8.1339(3)Å b=8.7424(4)Å c=12.4779(5)Å
α=90.00° β=96.933(4)° γ=90.00°
C7H8N3O3
C7H8N3O3
CrystEngComm (2012) 14, 7 2579
a=3.8701(4)Å b=17.3536(18)Å c=12.4978(13)Å
α=90.00° β=95.859(2)° γ=90.00°
111 GASM 14D sovate
C7H6O5,C4H5NO2,0.5(C4H8O2)
CrystEngComm (2016) 18, 18 3191
a=4.9477(2)Å b=10.5762(5)Å c=13.8911(7)Å
α=109.507(5)° β=95.486(4)° γ=101.807(4)°
111 GASM hydrate
C7H6O5,C4H5NO2,H2O
CrystEngComm (2016) 18, 18 3191
a=4.7352(2)Å b=16.3413(5)Å c=15.6208(9)Å
α=90° β=91.454(4)° γ=90°
221 GASM hydrate
2(C7H6O5),2(C4H5NO2),H2O
CrystEngComm (2016) 18, 18 3191
a=8.0698(4)Å b=10.3449(6)Å c=15.3908(10)Å
α=102.993(5)° β=91.110(5)° γ=109.434(5)°
421 GASM hydrate
2(C7H6O5),4(C4H5NO2),H2O
CrystEngComm (2016) 18, 18 3191
a=11.4899(7)Å b=13.1674(7)Å c=13.3084(10)Å
α=67.527(6)° β=67.492(7)° γ=64.740(6)°
331 GASM EtOAc solvate
3(C7H6O5),C4H6O2,3(C4H5NO2)
CrystEngComm (2016) 18, 18 3191
a=9.1318(4)Å b=14.0453(6)Å c=15.5062(7)Å
α=79.362(4)° β=85.337(3)° γ=79.211(3)°
221 GASM Act solvate
2(C7H6O5),2(C4H5NO2),C3H6O
CrystEngComm (2016) 18, 18 3191
a=8.2761(4)Å b=11.6893(6)Å c=14.7645(7)Å
α=108.269(4)° β=97.664(4)° γ=101.744(4)°
221 GASM THF solvate
2(C7H6O5),2(C4H5NO2),C4H8O
CrystEngComm (2016) 18, 18 3191
a=5.927(5)Å b=8.342(5)Å c=13.899(5)Å
α=79.829(5)° β=84.029(5)° γ=77.411(5)°
C7H7N3O3
C7H7N3O3
CrystEngComm (2012) 14, 7 2579
a=3.7408(7)Å b=17.352(2)Å c=12.558(2)Å
α=90.00° β=95.760(16)° γ=90.00°
Picolinic acid : Nicotinamide
C12H11N3O3
CrystEngComm (2017) 19, 7 1123
a=11.9096(10)Å b=5.5828(4)Å c=17.2361(15)Å
α=90.00° β=102.291(9)° γ=90.00°
Picolinic acid : Isonicotinamide
C12H11N3O3
CrystEngComm (2017) 19, 7 1123
a=6.9822(4)Å b=7.1747(5)Å c=12.7208(9)Å
α=76.298(6)° β=83.080(5)° γ=69.036(6)°
Aripiprazole hydrochloride salt
C23H28Cl2N3O2,Cl
CrystEngComm (2013) 15, 21 4321
a=10.2891(12)Å b=28.065(3)Å c=7.9247(9)Å
α=90.00° β=90.885(2)° γ=90.00°
Aripiprazole benzoate monohydrate
C23H28Cl2N3O2,C7H5O2,H2O
CrystEngComm (2013) 15, 21 4321
a=14.9688(10)Å b=9.9536(6)Å c=20.9154(14)Å
α=90.00° β=108.0040(10)° γ=90.00°
Aripiprazole-2,4-dihydoxybenzoate
C23H28Cl2N3O2,C7H5O4
CrystEngComm (2013) 15, 21 4321
a=15.1552(8)Å b=9.5732(5)Å c=21.5283(11)Å
α=90.00° β=103.8870(10)° γ=90.00°
Aripiprazole-2,5-dihydroxybenzoate hemihydrate
2(C23H28Cl2N3O2),2(C7H5O4),H2O
CrystEngComm (2013) 15, 21 4321
a=30.4165(19)Å b=9.7801(6)Å c=20.5636(13)Å
α=90.00° β=105.3190(10)° γ=90.00°
(C23H14O62),2(C4H12N5)
(C23H14O62),2(C4H12N5)
CrystEngComm (2013) 15, 22 4448
a=17.8097(8)Å b=7.9282(4)Å c=25.8018(9)Å
α=90.00° β=119.499(2)° γ=90.00°
2(C4H12N5),C23H14O62
2(C4H12N5),C23H14O62
CrystEngComm (2013) 15, 22 4448
a=7.4680(6)Å b=13.8016(11)Å c=16.2856(13)Å
α=73.334(1)° β=83.171(1)° γ=82.666(1)°
Furosemide sodium salt trihydrate
C12H10ClN2O5SNa.3H2O
CrystEngComm (2014) 16, 22 4842
a=20.9184(10)Å b=10.4771(6)Å c=7.8468(4)Å
α=90.00° β=95.790(4)° γ=90.00°
C14H17ClN4O5
C14H17ClN4O5
CrystEngComm (2014) 16, 42 9930
a=7.1364(4)Å b=14.8900(9)Å c=14.8390(7)Å
α=90.00° β=91.636(5)° γ=90.00°
C14H16.25ClN3.25O5.75
C14H16.25ClN3.25O5.75
CrystEngComm (2014) 16, 42 9930
a=7.0625(9)Å b=15.0679(19)Å c=14.7835(14)Å
α=90.00° β=90.563(9)° γ=90.00°
C14H16ClN3O6
C14H16ClN3O6
CrystEngComm (2014) 16, 42 9930
a=6.9766(3)Å b=15.2461(8)Å c=14.6100(7)Å
α=90.00° β=91.602(4)° γ=90.00°
C14H16.5ClN3.5O5.5
C14H16.5ClN3.5O5.5
CrystEngComm (2014) 16, 42 9930
a=7.0287(5)Å b=15.0835(11)Å c=14.7528(11)Å
α=90.00° β=90.090(6)° γ=90.00°
3(C7H6O4),C4H3NO2,3(H2O)
3(C7H6O4),C4H3NO2,3(H2O)
IUCrJ (2015) 2, Pt 3 341-351
a=9.3796(10)Å b=10.3981(12)Å c=15.6415(16)Å
α=80.620(9)° β=72.913(9)° γ=66.089(10)°
C11H10N4O3
C11H10N4O3
Crystal Growth & Design (2015) 15, 2 858
a=7.7932(5)Å b=8.0164(5)Å c=10.2555(7)Å
α=76.952(5)° β=77.240(5)° γ=61.961(6)°
C11H10N4O3
C11H10N4O3
Crystal Growth & Design (2015) 15, 2 858
a=9.2881(4)Å b=9.9444(4)Å c=12.4340(5)Å
α=95.507(4)° β=106.560(4)° γ=90.488(4)°
C9H11N5O4
C9H11N5O4
Crystal Growth & Design (2015) 15, 2 858
a=5.2384(9)Å b=28.141(5)Å c=7.8234(13)Å
α=90.00° β=91.938(14)° γ=90.00°
C14H22N6O6
C14H22N6O6
Crystal Growth & Design (2015) 15, 2 858
a=8.5450(9)Å b=10.4099(9)Å c=11.0248(11)Å
α=64.251(9)° β=83.081(8)° γ=86.219(7)°
C15H16N2O6S
C15H16N2O6S
Crystal Growth & Design (2015) 15, 7 3474
a=12.1306(3)Å b=8.6404(2)Å c=15.1096(4)Å
α=90.00° β=110.143(3)° γ=90.00°
C16H16N2O5
C16H16N2O5
Crystal Growth & Design (2015) 15, 7 3474
a=6.6720(5)Å b=9.7266(5)Å c=12.2504(6)Å
α=75.448(4)° β=77.839(5)° γ=76.928(5)°
C8H12NO3,C14H9N2O8
C8H12NO3,C14H9N2O8
Crystal Growth & Design (2015) 15, 7 3474
a=8.4250(5)Å b=11.0485(5)Å c=11.9865(5)Å
α=95.465(4)° β=97.045(4)° γ=103.775(4)°
C8H12NO3,C7H5O3
C8H12NO3,C7H5O3
Crystal Growth & Design (2015) 15, 7 3474
a=15.2676(15)Å b=6.8912(7)Å c=26.705(3)Å
α=90° β=95.223(10)° γ=90°
C8H12NO3,C7H6NO2
C8H12NO3,C7H6NO2
Crystal Growth & Design (2015) 15, 7 3474
a=6.9930(7)Å b=12.7693(8)Å c=15.8817(15)Å
α=89.049(6)° β=89.901(8)° γ=81.410(7)°
C10H13N3O4
C10H13N3O4
Crystal Growth & Design (2014) 14, 8 4187
a=5.7188(4)Å b=10.1645(7)Å c=20.4591(11)Å
α=90° β=90° γ=90°
C4H7NO3
C4H7NO3
Crystal Growth & Design (2014) 14, 8 4187
a=5.6612(3)Å b=5.1428(3)Å c=9.5438(5)Å
α=90° β=93.246(5)° γ=90°
C10H8N2,C4H6O4
C10H8N2,C4H6O4
Crystal Growth & Design (2014) 14, 8 4187
a=5.4131(6)Å b=6.0085(5)Å c=9.9526(8)Å
α=87.699(7)° β=84.940(8)° γ=73.561(9)°
C10H8N2,2(C4H7NO3)
C10H8N2,2(C4H7NO3)
Crystal Growth & Design (2014) 14, 8 4187
a=7.1751(6)Å b=10.1669(12)Å c=12.6992(12)Å
α=82.037(9)° β=81.412(7)° γ=88.251(8)°
C5H6N2O2S
C5H6N2O2S
Crystal Growth & Design (2012) 12, 9 4567
a=4.8946(3)Å b=15.4818(8)Å c=8.7607(5)Å
α=90.00° β=95.185(5)° γ=90.00°
C5H6N2O2S
C5H6N2O2S
Crystal Growth & Design (2012) 12, 9 4567
a=4.9893(9)Å b=7.0628(16)Å c=9.7308(16)Å
α=108.250(2)° β=94.716(3)° γ=96.499(3)°
C5H5NO3S
C5H5NO3S
Crystal Growth & Design (2012) 12, 9 4567
a=5.4285(16)Å b=15.583(5)Å c=7.6802(19)Å
α=90.00° β=108.61(3)° γ=90.00°
C5H5N3O
C5H5N3O
Crystal Growth & Design (2010) 10, 9 3931
a=14.315(2)Å b=3.6238(5)Å c=10.6158(15)Å
α=90.00° β=101.119(2)° γ=90.00°
C5H5N3O
C5H5N3O
Crystal Growth & Design (2010) 10, 9 3931
a=7.170(3)Å b=3.6477(15)Å c=10.648(4)Å
α=90.00° β=106.350(6)° γ=90.00°
C5H5N3O
C5H5N3O
Crystal Growth & Design (2010) 10, 9 3931
a=7.1756(14)Å b=3.6508(7)Å c=10.663(2)Å
α=90.00° β=106.337(3)° γ=90.00°
Pyrogallol
C6H6O3
Crystal Growth & Design (2012) 12, 8 3944
a=12.1144(11)Å b=3.7765(3)Å c=13.1365(12)Å
α=90.00° β=115.4840(10)° γ=90.00°
1:1 complex of pyrogallol and pyrazinamide
C6H6O3,C5H5N3O
Crystal Growth & Design (2012) 12, 8 3944
a=6.687(9)Å b=7.074(9)Å c=11.721(16)Å
α=80.61(2)° β=87.92(2)° γ=76.02(2)°
2:4 complex of pyrogallol and isonicotinamide
C6H6O3,2(C6H6N2O)
Crystal Growth & Design (2012) 12, 8 3944
a=17.056(2)Å b=5.8142(7)Å c=18.163(2)Å
α=90.00° β=100.886(2)° γ=90.00°
2:1 complex of pyrogallol and isonicotinamide
C6H6O3,0.5(C6H6N2O)
Crystal Growth & Design (2012) 12, 8 3944
a=9.2540(8)Å b=9.5435(9)Å c=10.0539(9)Å
α=72.4640(10)° β=83.730(2)° γ=80.0920(10)°
2:1 complex of pyrogallol and nicotinamide
C6H6O3,0.5(C6H6N2O)
Crystal Growth & Design (2012) 12, 8 3944
a=11.2860(13)Å b=19.551(2)Å c=7.8342(9)Å
α=90.00° β=108.082(2)° γ=90.00°
3:5 complex of pyrogallol and quinoline
3(C6H6O3),5(C9H7N)
Crystal Growth & Design (2012) 12, 8 3944
a=8.0271(16)Å b=16.182(3)Å c=20.306(4)Å
α=74.727(3)° β=86.151(4)° γ=85.632(4)°
2:3 complex of pyrogallol and quinoline
3(C9H7N),2(C6H6O3)
Crystal Growth & Design (2012) 12, 8 3944
a=7.5553(8)Å b=11.6292(13)Å c=18.763(2)Å
α=88.645(9)° β=80.688(9)° γ=76.572(10)°
1:2 complex of pyrogallol and 2 hydroxyquinoline
2(C9H7NO),C6H6O3
Crystal Growth & Design (2012) 12, 8 3944
a=7.6809(7)Å b=10.0076(9)Å c=13.4348(12)Å
α=73.3500(10)° β=82.756(2)° γ=84.385(2)°
1.5(C10H8N2),C6H6O3,H2O
1.5(C10H8N2),C6H6O3,H2O
Crystal Growth & Design (2012) 12, 8 3944
a=9.3257(10)Å b=9.5756(10)Å c=24.020(3)Å
α=91.162(2)° β=95.450(2)° γ=116.545(2)°
Pyrogallol 0.25 hydrate
C6H6O3,0.25(H2O)
Crystal Growth & Design (2012) 12, 8 3944
a=24.5039(12)Å b=24.5039(12)Å c=3.7849(4)Å
α=90.00° β=90.00° γ=90.00°
C8H11NO6S
C8H11NO6S
Crystal Growth & Design (2013) 13, 4 1551
a=5.3525(5)Å b=17.8159(12)Å c=11.0537(10)Å
α=90.00° β=99.057(8)° γ=90.00°
C15H19N7O6
C15H19N7O6
Crystal Growth & Design (2013) 13, 4 1551
a=7.4285(6)Å b=22.0769(18)Å c=10.9219(10)Å
α=90.00° β=101.461(9)° γ=90.00°
C13H15N3O5
C13H15N3O5
Crystal Growth & Design (2013) 13, 4 1551
a=6.750(2)Å b=7.060(2)Å c=14.809(4)Å
α=95.977(4)° β=97.899(5)° γ=104.722(4)°
C14H16N2O10S
C14H16N2O10S
Crystal Growth & Design (2013) 13, 4 1551
a=15.7940(16)Å b=19.897(2)Å c=5.5179(6)Å
α=90.00° β=90.00° γ=90.00°
C7H10NNaO5
C7H10NNaO5
Crystal Growth & Design (2013) 13, 4 1551
a=8.790(4)Å b=14.615(7)Å c=6.955(3)Å
α=90.00° β=97.799(8)° γ=90.00°
C7H7NO3
C7H7NO3
Crystal Growth & Design (2013) 13, 4 1551
a=3.7161(4)Å b=7.3629(9)Å c=23.307(3)Å
α=90.00° β=91.889(2)° γ=90.00°
C10H26Cl2N2O2
C10H26Cl2N2O2
Crystal Growth & Design (2013) 13, 4 1752
a=6.432(2)Å b=22.966(9)Å c=5.0934(19)Å
α=90.00° β=90.00° γ=90.00°
C10H24N2O2
C10H24N2O2
Crystal Growth & Design (2013) 13, 4 1752
a=7.1428(3)Å b=8.4149(3)Å c=10.1973(4)Å
α=90.00° β=95.633(4)° γ=90.00°
Furosemide potassuium salt monohydrate
C12H10ClN2O5SK.H2O
CrystEngComm (2014) 16, 22 4842
a=18.8967(10)Å b=11.1734(6)Å c=7.3056(4)Å
α=90.00° β=91.346(5)° γ=90.00°
C12H12N2O8
C12H12N2O8
Crystal Growth & Design (2015) 15, 2 858
a=6.2822(2)Å b=13.4037(4)Å c=15.5274(6)Å
α=90.00° β=93.563(3)° γ=90.00°
C5H5NO3S
C5H5NO3S
Crystal Growth & Design (2012) 12, 9 4567
a=7.1874(3)Å b=11.4435(5)Å c=14.9673(9)Å
α=90.00° β=90.00° γ=90.00°
C11H12N4O4
C11H12N4O4
Crystal Growth & Design (2013) 13, 4 1551
a=12.6069(17)Å b=13.6925(18)Å c=14.595(2)Å
α=90.00° β=110.973(3)° γ=90.00°
C12H32N2O8S2
C12H32N2O8S2
Crystal Growth & Design (2013) 13, 4 1752
a=12.239(3)Å b=15.151(3)Å c=5.2980(11)Å
α=90.00° β=90.00° γ=90.00°
C28H58N4O13
C28H58N4O13
Crystal Growth & Design (2013) 13, 4 1752
a=8.5813(6)Å b=10.5252(8)Å c=10.9210(8)Å
α=70.6260(10)° β=68.8720(10)° γ=73.8670(10)°